CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study

Abroad (travel likely)Recruiting

Conditions

Cardiac Amyloidosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sanger Heart and Vascular Institute, Charlotte, North Carolina, United States
Contact: Study coordinator (Dana B Amaro, RN) · Dana.Amaro@atriumhealth.org · 704-355-4692
Contact: Principal Investigator (Jai Singh, MD)

Study leads

Jai Singh, MD
Principal Investigator
Wake Forest University Health Sciences

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Amyloidosis · Amyloid Cardiomyopathy · Transthyretin Amyloidosis

Abroad (travel likely)RecruitingPHASE3

La Jolla, United States · Los Angeles, United States

PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY

Cardiac Amyloidosis

Abroad (travel likely)Recruiting

London, United Kingdom

Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis

Lumbar Spinal Stenosis · Cardiac Amyloidosis · ATTR Amyloidosis Wild Type

Abroad (travel likely)Recruiting

Beverly Hills, United States · Boston, United States

Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure

Cardiac Amyloidosis

Abroad (travel likely)Recruiting

Paris, France · Nantes, France